Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

CD22-targeted immunoconjugate characterized at EORTC-NCI-AACR meeting

Nov. 27, 2002

A novel prostate cancer vaccine reported to induce specific immune responses

Nov. 27, 2002

New data on the immunomodulatory effects of IL-2 + histamine in advanced melanoma

Nov. 27, 2002

MLN-2704 enters phase I in androgen-independent prostate cancer

Nov. 26, 2002

Ivax to develop LMB-9

Nov. 25, 2002

IGN-311 reported safe in rhesus monkeys

Nov. 22, 2002

CC-5013 effective and well tolerated in multiple myeloma

Nov. 22, 2002

Enrollment completed for BLP25 liposomal vaccine study in non-small cell lung cancer

Nov. 19, 2002

Albuleukin superior to rIL-2 in mouse model of metastatic melanoma

Nov. 18, 2002

Potential use of vaccines in advanced prostate cancer

Nov. 15, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...